The history of Viagra and its impact on the pharmaceutical sector presents a intricate question regarding its continued viability as an investment. Initially a blockbuster success, generating billions , generic competition has significantly eroded earnings . While major pharmaceutical firms continue patents on related therapies and explore new form

The trajectory of companies tied to iconic drugs like Viagra presents a challenging investment scenario . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the expiry in key regions has introduced significant risk . Investors are now grappling with the effect of rival medications , diminis